ALPHARETTA, Ga.--(BUSINESS WIRE)--Clearside Biomedical, which develops first-in-class drug therapies to treat diseases of the eye, announces enrollment of 50th patient using suprachoroidal (SCS™) drug administration.
| < Prev | Next > |
|---|
- Hunt for Queen's Wharf developer commences
- Magazine seeks writers for online column in U.S.A, U.K., Asia & Australia. Writers wanted
- Queensland unit and townhouse sales climb
- Perth median house price at new record
- Don’t let a bad credit score ruin your chances of a home loan
- The Importance of Communication for Business Success
- The Workers Launch Balmain's Biggest Laugh Free Live Comedy
- UK Innovator Visa: Getting Endorsement
- Respected local restaurateurs are the icing on the Tweed River Art Gallery
- Lonely Planet names Kimberley as world’s second top tourism region for 2014
- Surplus signals time for NSW Government to cut stamp duty
- Businesses
- Record harvest ensures city fruit and veg supplies
- Katter calls for better delivery of drought assistance
- The Global Forest Industry This Quarter
- Jazz Degustation + The Cellar Jazz Jam
- Progress for Canning Basin exploration
- ACCC action after chicken companies made false claims
- Commercial gas expansion boosts WA economy
- Vegan Australia says no to Bacon Week
